These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 7932409

  • 1. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis.
    Després N, Boire G, Lopez-Longo FJ, Ménard HA.
    J Rheumatol; 1994 Jun; 21(6):1027-33. PubMed ID: 7932409
    [Abstract] [Full Text] [Related]

  • 2. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis.
    Hayem G, Chazerain P, Combe B, Elias A, Haim T, Nicaise P, Benali K, Eliaou JF, Kahn MF, Sany J, Meyer O.
    J Rheumatol; 1999 Jan; 26(1):7-13. PubMed ID: 9918234
    [Abstract] [Full Text] [Related]

  • 3. Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodies.
    Escalona M, López-Longo FJ, González CM, Monteagudo I, Rodríguez-Mahou M, Grau R, Carreño L.
    J Rheumatol; 2002 Oct; 29(10):2053-60. PubMed ID: 12375311
    [Abstract] [Full Text] [Related]

  • 4. [Study of the proteins associated with Sa antigen].
    Chen H, Yao ZJ, Tang FL.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 18; 86(27):1896-900. PubMed ID: 17064527
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-Sa antibody in Chinese rheumatoid arthritis.
    Xu S, Tang F, Shi L, Gan X, Shi Y, Cheng L, Li J, Dong Y.
    Chin Med J (Engl); 1998 Mar 18; 111(3):204-7. PubMed ID: 10374415
    [Abstract] [Full Text] [Related]

  • 8. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.
    Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA.
    Arthritis Res Ther; 2005 Mar 18; 7(3):R592-603. PubMed ID: 15899046
    [Abstract] [Full Text] [Related]

  • 9. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A, Plischke H, Kellner H, Gruber R.
    Ann N Y Acad Sci; 2005 Jun 18; 1050():295-303. PubMed ID: 16014545
    [Abstract] [Full Text] [Related]

  • 10. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct 18; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 11. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F, Foschi FG, Bedeschi E, Calderoni V, Stefanini GF, Martinelli MG.
    Eur Ann Allergy Clin Immunol; 2004 Apr 18; 36(4):127-30. PubMed ID: 15180353
    [Abstract] [Full Text] [Related]

  • 12. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
    Hill JA, Al-Bishri J, Gladman DD, Cairns E, Bell DA.
    J Rheumatol; 2006 Nov 18; 33(11):2115-9. PubMed ID: 16924693
    [Abstract] [Full Text] [Related]

  • 13. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C, Riente L, Pratesi F, Chimenti D, Delle Sedie A, Bombardieri S, Migliorini P.
    Rheumatology (Oxford); 2007 Oct 18; 46(10):1579-82. PubMed ID: 17717033
    [Abstract] [Full Text] [Related]

  • 14. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.
    Saulot V, Vittecoq O, Charlionet R, Fardellone P, Lange C, Marvin L, Machour N, Le Loët X, Gilbert D, Tron F.
    Arthritis Rheum; 2002 May 18; 46(5):1196-201. PubMed ID: 12115223
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ.
    Arthritis Rheum; 2003 Oct 18; 48(10):2741-9. PubMed ID: 14558078
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.
    J Rheumatol; 2009 Apr 18; 36(4):712-6. PubMed ID: 19286846
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.
    Arthritis Rheum; 2000 Jan 18; 43(1):155-63. PubMed ID: 10643712
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.
    J Rheumatol; 2007 Aug 18; 34(8):1658-63. PubMed ID: 17611988
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.